| PASC | Post-acute sequelae of COVID-19 |
| LC | Long COVID |
| ACE | Angiotensin-converting enzyme |
| ACE2 | Angiotensin-converting enzyme 2 |
| rhACE2 | Recombinant human angiotensin-converting enzyme 2 |
| RBD | Receptor-binding domain |
| RBM | Receptor-binding motif |
| mAb/mAbs | Monoclonal antibody/Monoclonal antibodies |
| Ab/Abs | Antibody/Antibodies |
| EDTA | ethylenediaminetetraacetic acid |
| Vmax | Maximum velocity |
| Km | Michaelis constant |
| GI | Gastrointestinal |
| abzymes | Antibodies with catalytic activity |
| kcat | Turnover number |
| S | SARS-CoV-2 Spike protein |
| FP | SARS-CoV-2 fusion peptide |
| DMEM | Dulbecco’s Modified Eagle Medium |
| FBS | Fetal bovine serum |
| MES | 2-(N-morpholino)ethanesulfonic acid |
| ELISA | Enzyme-Linked Immunosorbent Assay |
| ddH2O | Double-distilled water |
| DMSO | dimethyl sulfoxide |
| MCA | 7-methoxycoumarin-4-acetic acid |
| RFU | Relative fluorescence units |
| IgG | Immunoglobulin G |
| SLE | Systemic lupus erythematosus |
| CDR | Complementarity-determining region |
| HPLC | High-performance liquid chromatography |